Workplace social capital and adherence to antihypertensive medication: a cohort study.
While hypertension is a common and treatable health problem, adherence to antihypertensive medication remains a challenge. This study examines the hypothesis that workplace social capital may influence adherence to antihypertensive medication among hypertensive employees.We linked survey responses t...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3170374?pdf=render |
id |
doaj-cb2b0e87895f468c926c56f99725455a |
---|---|
record_format |
Article |
spelling |
doaj-cb2b0e87895f468c926c56f99725455a2020-11-25T01:33:45ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0169e2473210.1371/journal.pone.0024732Workplace social capital and adherence to antihypertensive medication: a cohort study.Tuula OksanenIchiro KawachiAnne KouvonenEtsuji SuzukiSoshi TakaoNoora SjöstenMarianna VirtanenJaana PenttiJussi VahteraMika KivimäkiWhile hypertension is a common and treatable health problem, adherence to antihypertensive medication remains a challenge. This study examines the hypothesis that workplace social capital may influence adherence to antihypertensive medication among hypertensive employees.We linked survey responses to nationwide pharmacy records for a cohort of 3515 hypertensive employees (mean age 53.9 years, 76% women) who required continuous antihypertensive drug therapy (the Finnish Public Sector study). A standard scale was used to measure workplace social capital from co-workers' assessments and self-reports in 2000-2004. Non-adherence to antihypertensive medication was determined based on the number of days-not-treated at the year following the survey using comprehensive prescription records. Negative binomial regression models were conducted adjusting for socio-demographic characteristics, duration of hypertension, behaviour-related risk factors, and co-morbid conditions. The overall rate of days-not-treated was 20.7 per person-year (78% had no days-not-treated). Higher age, obesity, and presence of somatic co-morbidities were all associated with better adherence, but this was not the case for co-worker-assessed or self-reported workplace social capital. The rate of days-not-treated was 19.7 per person-year in the bottom fourth of co-worker-assessed workplace social capital, compared to 20.4 in the top fourth. The corresponding rate ratio from the fully-adjusted model was 0.95 (95% confidence interval (CI) 0.58-1.56). In a subgroup of 907 new users of antihypertensive medication this rate ratio was 0.98 (95% CI 0.42-2.29).We found no consistent evidence to support the hypothesized effect of workplace social capital on adherence to drug therapy among employees with chronic hypertension.http://europepmc.org/articles/PMC3170374?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tuula Oksanen Ichiro Kawachi Anne Kouvonen Etsuji Suzuki Soshi Takao Noora Sjösten Marianna Virtanen Jaana Pentti Jussi Vahtera Mika Kivimäki |
spellingShingle |
Tuula Oksanen Ichiro Kawachi Anne Kouvonen Etsuji Suzuki Soshi Takao Noora Sjösten Marianna Virtanen Jaana Pentti Jussi Vahtera Mika Kivimäki Workplace social capital and adherence to antihypertensive medication: a cohort study. PLoS ONE |
author_facet |
Tuula Oksanen Ichiro Kawachi Anne Kouvonen Etsuji Suzuki Soshi Takao Noora Sjösten Marianna Virtanen Jaana Pentti Jussi Vahtera Mika Kivimäki |
author_sort |
Tuula Oksanen |
title |
Workplace social capital and adherence to antihypertensive medication: a cohort study. |
title_short |
Workplace social capital and adherence to antihypertensive medication: a cohort study. |
title_full |
Workplace social capital and adherence to antihypertensive medication: a cohort study. |
title_fullStr |
Workplace social capital and adherence to antihypertensive medication: a cohort study. |
title_full_unstemmed |
Workplace social capital and adherence to antihypertensive medication: a cohort study. |
title_sort |
workplace social capital and adherence to antihypertensive medication: a cohort study. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2011-01-01 |
description |
While hypertension is a common and treatable health problem, adherence to antihypertensive medication remains a challenge. This study examines the hypothesis that workplace social capital may influence adherence to antihypertensive medication among hypertensive employees.We linked survey responses to nationwide pharmacy records for a cohort of 3515 hypertensive employees (mean age 53.9 years, 76% women) who required continuous antihypertensive drug therapy (the Finnish Public Sector study). A standard scale was used to measure workplace social capital from co-workers' assessments and self-reports in 2000-2004. Non-adherence to antihypertensive medication was determined based on the number of days-not-treated at the year following the survey using comprehensive prescription records. Negative binomial regression models were conducted adjusting for socio-demographic characteristics, duration of hypertension, behaviour-related risk factors, and co-morbid conditions. The overall rate of days-not-treated was 20.7 per person-year (78% had no days-not-treated). Higher age, obesity, and presence of somatic co-morbidities were all associated with better adherence, but this was not the case for co-worker-assessed or self-reported workplace social capital. The rate of days-not-treated was 19.7 per person-year in the bottom fourth of co-worker-assessed workplace social capital, compared to 20.4 in the top fourth. The corresponding rate ratio from the fully-adjusted model was 0.95 (95% confidence interval (CI) 0.58-1.56). In a subgroup of 907 new users of antihypertensive medication this rate ratio was 0.98 (95% CI 0.42-2.29).We found no consistent evidence to support the hypothesized effect of workplace social capital on adherence to drug therapy among employees with chronic hypertension. |
url |
http://europepmc.org/articles/PMC3170374?pdf=render |
work_keys_str_mv |
AT tuulaoksanen workplacesocialcapitalandadherencetoantihypertensivemedicationacohortstudy AT ichirokawachi workplacesocialcapitalandadherencetoantihypertensivemedicationacohortstudy AT annekouvonen workplacesocialcapitalandadherencetoantihypertensivemedicationacohortstudy AT etsujisuzuki workplacesocialcapitalandadherencetoantihypertensivemedicationacohortstudy AT soshitakao workplacesocialcapitalandadherencetoantihypertensivemedicationacohortstudy AT noorasjosten workplacesocialcapitalandadherencetoantihypertensivemedicationacohortstudy AT mariannavirtanen workplacesocialcapitalandadherencetoantihypertensivemedicationacohortstudy AT jaanapentti workplacesocialcapitalandadherencetoantihypertensivemedicationacohortstudy AT jussivahtera workplacesocialcapitalandadherencetoantihypertensivemedicationacohortstudy AT mikakivimaki workplacesocialcapitalandadherencetoantihypertensivemedicationacohortstudy |
_version_ |
1725075913552429056 |